THANK YOU FOR SUBSCRIBING
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
![]()
Precisis offers a minimally invasive precise and personalized neurostimulation platform that eases out the conditions for people with focal epilepsy where drugs fail to yield results
Share this Article:
Tweet
|
Company
Precisis
Headquarters
Heidelberg, Germany
Management
Dr. Angela Liedler, CEO
Description
Precisis has built a technology aimed at improving the lives of patients who have epilepsy and other brain diseases. Precisis offers individualized and precise treatment methods in the field of neurostimulation that focuses on cortex stimulation procedure. Their innovation platform EASEE® or Epicranial Application of Stimulation Electrodes to Ease brain symptoms is suitable for individuals with epilepsy for whom medication no longer works or undergoing brain resection is out of the question. EASEE® can also be set up to target other brain diseases such as cognitive dysfunction, depression and rehabilitation after stroke.EASEE® offers a precise, individualized, and personalized stimulation through an easy surgical procedure.
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info